| A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis (NCT06099535) | Lynk Pharmaceuticals Co., Ltd | 2021-11-18 |
| Levocarnitine for Dry Eye in Sjogren's Syndrome (NCT03953703) | Vanderbilt University Medical Center | 2021-11-17 |
| A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection (NCT04978337) | Janssen Research & Development, LLC | 2021-11-17 |
| Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm (NCT05113355) | Peking Union Medical College Hospital | 2021-11-17 |
| Obinutuzumab in Primary FSGS (NCT04983888) | Mayo Clinic | 2021-11-17 |
| Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (NCT05045950) | Medical College of Wisconsin | 2021-11-17 |
| Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection (NCT04934527) | University Hospital, Bordeaux | 2021-11-17 |
| A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause (NCT05034042) | Astellas Pharma Inc | 2021-11-17 |
| Medication Development in Alcoholism: Suvorexant Versus Placebo (NCT04229095) | The Scripps Research Institute | 2021-11-17 |
| A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age (NCT05127434) | ModernaTX, Inc. | 2021-11-17 |
| A Study of Lu AF82422 in Participants With Multiple System Atrophy (NCT05104476) | H. Lundbeck A/S | 2021-11-16 |
| Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery (NCT04791943) | Montefiore Medical Center | 2021-11-16 |
| Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients (NCT05119686) | Arthrosi Therapeutics | 2021-11-16 |
| Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration. (NCT05142553) | Hipra Scientific, S.L.U | 2021-11-16 |
| Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (NCT05123196) | Tanabe Pharma Corporation | 2021-11-16 |
| ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy (NCT05065554) | Shayna Sarosiek, MD | 2021-11-16 |
| A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis (NCT05044234) | AbbVie | 2021-11-16 |
| A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care Medications (NCT04353661) | Genentech, Inc. | 2021-11-16 |
| OH2 Oncolytic Viral Therapy in Central Nervous System Tumors (NCT05235074) | Binhui Biopharmaceutical Co., Ltd. | 2021-11-16 |
| Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer (NCT05211557) | The Affiliated Hospital of Xuzhou Medical University | 2021-11-16 |
| Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress (NCT04903327) | Sorrento Therapeutics, Inc. | 2021-11-16 |
| Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG) (NCT05131711) | Beijing Tiantan Hospital | 2021-11-16 |
| Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress (NCT04905836) | Sorrento Therapeutics, Inc. | 2021-11-16 |
| A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) (NCT05035836) | M.D. Anderson Cancer Center | 2021-11-16 |
| Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US) (NCT04906694) | Sorrento Therapeutics, Inc. | 2021-11-16 |
| Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma (NCT04951583) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-11-16 |
| A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) (NCT05210868) | Beijing InnoCare Pharma Tech Co., Ltd. | 2021-11-16 |
| Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NCT05014815) | BeiGene | 2021-11-16 |
| Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer (NCT05071053) | Sanofi | 2021-11-16 |
| Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy (NCT04975555) | University of Alabama at Birmingham | 2021-11-15 |
| Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder (NCT04884763) | Indiana University | 2021-11-15 |
| Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG) (NCT06903156) | Pharmasoft | 2021-11-15 |
| A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma (NCT04455139) | Prof. Beck Popovic Maja | 2021-11-15 |
| Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis (NCT04885972) | Sorrento Therapeutics, Inc. | 2021-11-15 |
| Polypill Strategy for Heart Failure With Reduced Ejection Fraction (NCT04633005) | University of Texas Southwestern Medical Center | 2021-11-15 |
| Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis (NCT05186805) | Organon and Co | 2021-11-15 |
| Perioperative Intravenous Lidocaine in Liver Surgery (NCT05153785) | Lund University Hospital | 2021-11-15 |
| Evaluation of Common Bean Baked Snack Consumption on Subjective Satiety, Energy Intake and Glycemic Response in People With Overweight and Normal Weight (NCT05230979) | Centro Universitario de Ciencias de la Salud, Mexico | 2021-11-15 |
| Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma (NCT05036434) | National Cancer Center, Korea | 2021-11-15 |
| DMT310-005 Topical in the Treatment of Acne Rosacea (NCT05108025) | Dermata Therapeutics | 2021-11-15 |
| Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy (NCT05665036) | Sigilon Therapeutics, Inc. | 2021-11-15 |
| A Phase II Clinical Trial to Evaluate HLX208 in Advanced Non-small Cell Lung Cancer Patients With BRAF V600 Mutation (NCT05065398) | Shanghai Henlius Biotech | 2021-11-15 |
| Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease (NCT05122598) | Evon Medics LLC | 2021-11-15 |
| Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis (NCT05118256) | Instituto de investigación e innovación biomédica de Cádiz | 2021-11-15 |
| A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NCT05397379) | Sunshine Lake Pharma Co., Ltd. | 2021-11-15 |
| Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers. (NCT05060887) | Osivax | 2021-11-15 |
| Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke (NCT04984577) | Nanjing Yoko Biomedical Co., Ltd. | 2021-11-15 |
| A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD (NCT03919162) | Vivoryon Therapeutics N.V. | 2021-11-15 |
| NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC (NCT04984811) | NeoImmuneTech | 2021-11-15 |
| Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors (NCT05142592) | Nanjing Immunophage Biotech Co., Ltd | 2021-11-15 |
| Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC (NCT04952753) | Novartis Pharmaceuticals | 2021-11-15 |
| Study to Evaluate ARD-101 in Adults With Obesity (NCT05121441) | Aardvark Therapeutics, Inc. | 2021-11-15 |
| Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors (NCT05522582) | Yancheng First People's Hospital | 2021-11-15 |
| Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (NCT05080790) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2021-11-15 |
| Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease (NCT04819841) | Kamau Therapeutics | 2021-11-15 |
| Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors (NCT05024214) | 3D Medicines (Sichuan) Co., Ltd. | 2021-11-15 |
| A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels (NCT05487404) | Aldeyra Therapeutics, Inc. | 2021-11-15 |
| Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures (NCT04851717) | Acacia Pharma Ltd | 2021-11-15 |
| Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS (NCT04749355) | BioSight Ltd. | 2021-11-14 |
| A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis (NCT05176093) | Helixmith Co., Ltd. | 2021-11-14 |
| An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS (NCT05299658) | Clene Nanomedicine | 2021-11-13 |
| ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma (NCT05014464) | Hunan Province Tumor Hospital | 2021-11-13 |
| Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis (NCT04925557) | State University of New York at Buffalo | 2021-11-13 |
| Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary (NCT05241132) | Wei Xu | 2021-11-12 |
| A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC (NCT05236608) | National University Hospital, Singapore | 2021-11-12 |
| SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer (NCT05160896) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-11-12 |
| Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation (NCT05205863) | Prothya Biosolutions | 2021-11-12 |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG) (NCT05281406) | Goethe University | 2021-11-12 |
| A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) (NCT05020015) | Takeda | 2021-11-12 |
| Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma (NCT04561206) | City of Hope Medical Center | 2021-11-12 |
| Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) (NCT05038332) | University of Michigan Rogel Cancer Center | 2021-11-12 |
| A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones (NCT05133440) | Memorial Sloan Kettering Cancer Center | 2021-11-12 |
| Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease (NCT04855305) | Bastiaan Driehuys | 2021-11-12 |
| Nitrous Oxide as Treatment for Fibromyalgia (NCT05357066) | University of Chicago | 2021-11-12 |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer (NCT04628767) | National Cancer Institute (NCI) | 2021-11-12 |
| Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant (NCT04908735) | Children's Hospital Medical Center, Cincinnati | 2021-11-12 |
| Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia (NCT05057221) | Lena Napolitano, MD | 2021-11-12 |
| Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma (NCT06021678) | Guangzhou Excelmab Inc. | 2021-11-12 |
| A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis (NCT05020652) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-11-11 |
| An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer (NCT04745988) | National Cancer Center Hospital East | 2021-11-11 |
| Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC (NCT05158491) | JenKem Technology Co., Ltd. | 2021-11-11 |
| A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments (NCT05133323) | H. Lundbeck A/S | 2021-11-11 |
| Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor (NCT06470464) | Shandong First Medical University | 2021-11-11 |
| Hypopharynx ICG to Reduce the Fistula Rate in Patients Undergoing Salvage Laryngectomy (NCT05350540) | University Health Network, Toronto | 2021-11-11 |
| Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (NCT05255653) | Leiden University Medical Center | 2021-11-11 |
| Treatment for Migraine and Mood (Team-M) (NCT04992494) | NYU Langone Health | 2021-11-11 |
| A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease (NCT05036473) | Shanghai WD Pharmaceutical Co., Ltd. | 2021-11-11 |
| Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation (NCT04838041) | Medical College of Wisconsin | 2021-11-11 |
| Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO) (NCT05147415) | Saniona | 2021-11-11 |
| Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen (NCT04837196) | Astellas Pharma Global Development, Inc. | 2021-11-11 |
| Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children (NCT05116241) | ILiAD Biotechnologies | 2021-11-11 |
| Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study (NCT05328336) | Tianjin Medical University Second Hospital | 2021-11-11 |
| Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) (NCT05142514) | Hipra Scientific, S.L.U | 2021-11-11 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) (NCT04691570) | Annexon, Inc. | 2021-11-10 |
| Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV (NCT05205083) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-11-10 |
| Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma. (NCT05176002) | Fujian Medical University Union Hospital | 2021-11-10 |
| Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19 (NCT04299152) | Throne Biotechnologies Inc. | 2021-11-10 |
| Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement (NCT05127421) | Incyte Corporation | 2021-11-10 |
| A Trial to Improve Quality of Life in People With Cirrhosis (NCT05061992) | University of Michigan | 2021-11-10 |
| A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102) (NCT05254899) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-11-10 |